Work

Myeloma Developing Regimens Using Genomics (MyDRUG): Longitudinal Single-Cell Transcriptional Landscape of the Myeloma and Immune Microenvironment in Relapsed/Refractory Multiple Myeloma Patients Treated with MEK-Inhibitor, Cobimetinib

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-167462

Authors: Reyka G. Jayasinghe, George Mulligan, April Cook, Mark Hamilton, Sacha Gnjatic, Seunghee Kim-Schulze, Hearn J. Cho, Shaji K Kumar

Institutions: Washington University in St. Louis, Multiple Myeloma Research Foundation, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Mayo Clinic

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310163312

FWCI: 0.156

Cites:

Cited by: 1

Related to: 10